BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35582997)

  • 1. Notch1/Hes1‑PTEN/AKT/IL‑17A feedback loop regulates Th17 cell differentiation in mouse psoriasis‑like skin inflammation.
    Lin YW; Li XX; Fu FH; Liu B; Xing X; Qi R; Ma L
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35582997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY294002 ameliorates psoriatic skin inflammation in mice via blocking the Notch1/Hes1-PTEN/AKT/IL-17A feedback loop.
    Lin Y; Zhu X; Li Y; Dou Y; Wang J; Qi R; Ma L
    Clin Exp Immunol; 2023 Jul; 213(1):114-124. PubMed ID: 36840628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation.
    Roy T; Banang-Mbeumi S; Boateng ST; Ruiz EM; Chamcheu RN; Kang L; King JA; Walker AL; Nagalo BM; Kousoulas KG; Esnault S; Huang S; Chamcheu JC
    Front Immunol; 2022; 13():1075804. PubMed ID: 36741386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling regulates Th17 cells differentiation through PI3K/AKT/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis.
    He C; Li Y; Gan L; Lin Y; Zhang B; Ma L; Xue H
    J Endocrinol Invest; 2024 Jan; ():. PubMed ID: 38285310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch-Hes1 Signaling Regulates IL-17A
    Wang Y; Li X; Xing X; Xue H; Qi R; Ji H; Ma L
    Mediators Inflamm; 2020; 2020():8297134. PubMed ID: 32454795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased microRNA-126 expression in psoriatic CD4
    Wu R; Li X; Li S; Tang G; Zhang S; Zhu Y; Zhang X; Deng M; Tan S; Luo S; Zhang Q; Zhao M; Zhang P; Su Y
    J Dermatol; 2022 Apr; 49(4):432-440. PubMed ID: 34931339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
    Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
    Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
    Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
    BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the mechanism of Fang-Ji-Di-Huang-Decoction in ameliorating psoriasis-like skin inflammation via the inhibition of IL-23/Th17 cell axis.
    Song C; Yang C; Meng S; Li M; Wang X; Zhu Y; Kong L; Lv W; Qiao H; Sun Y
    J Ethnopharmacol; 2021 Dec; 281():114571. PubMed ID: 34464701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein Kinase CK2 Promotes Proliferation, Abnormal Differentiation, and Proinflammatory Cytokine Production of Keratinocytes via Regulation of STAT3 and Akt Pathways in Psoriasis.
    Huang W; Zheng X; Huang Q; Weng D; Yao S; Zhou C; Li Q; Hu Y; Xu W; Huang K
    Am J Pathol; 2023 May; 193(5):567-578. PubMed ID: 37080661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K-Akt-mTORC1-S6K1/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORγ.
    Kurebayashi Y; Nagai S; Ikejiri A; Ohtani M; Ichiyama K; Baba Y; Yamada T; Egami S; Hoshii T; Hirao A; Matsuda S; Koyasu S
    Cell Rep; 2012 Apr; 1(4):360-73. PubMed ID: 22832227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
    Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
    FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (R)-Salbutamol Improves Imiquimod-Induced Psoriasis-Like Skin Dermatitis by Regulating the Th17/Tregs Balance and Glycerophospholipid Metabolism.
    Liu F; Wang S; Liu B; Wang Y; Tan W
    Cells; 2020 Feb; 9(2):. PubMed ID: 32102363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Emerging Role of
    Yang Y; Zhao Y; Lai R; Xian L; Lei Q; Xu J; Guo M; Xian D; Zhong J
    Oxid Med Cell Longev; 2022; 2022():5800586. PubMed ID: 35720176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.